Molecular mechanisms of cyclosporin A inhibition of the cytokine-induced matrix metalloproteinase-9 in glomerular mesangial cells

Journal of the American Society of Nephrology

Volumn 18, Issue 2, 2007, Pages 581-592

  Doller, Anke ^a   Akool, El Sayed ^a   Müller, Roswitha ^a   Gutwein, Paul ^a   Kurowski, Christine ^a   Pfeilschifter, Josef ^a   Eberhardt, Wolfgang ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CYCLOSPORIN A; CYTOKINE; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LUCIFERASE; MESSENGER RNA; PEPTIDE; PROTEIN P42; PROTEIN P44; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOTAGMIN I; TACROLIMUS; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; VALYLISOLEUCYLVALYLISOLEUCYLTHREONINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DNA BINDING; DOSE RESPONSE; ENZYME ASSAY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GEL MOBILITY SHIFT ASSAY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FIBROSIS; LONG TERM CARE; MESANGIUM; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; RAT; TRANSCRIPTION REGULATION;

EID: 33846654163     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006060568     Document Type: Article

References (38)

1. Fellstrom B: Cyclosporine nephrotoxicity. Transplant Proc 36: 220S-223S, 2004
2. Schreiber SL, Crabtree GR: The mechanism of action of cyclosporin A and FK506. Immunol Today 13: 136-142, 1992
3. Rao A, Luo C, Hogan PG: Transcription factors of the NFAT family: Regulation and function. Annu Rev Immunol 15: 707-747, 1997
4. Boss V, Talpade DJ, Murphy TJ: Induction of NFAT-mediated transcription by Gq-coupled receptors in lymphoid and non-lymphoid cells. J Biol Chem 271: 10429-10432, 1996
5. Muhl H, Kunz D, Rob P, Pfeilschifter J: Cyclosporin derivatives inhibit interleukin 1beta induction of nitric oxide synthase in renal mesangial cells. Eur J Pharmacol 249: 95-100, 1993
6. Walker G, Kunz D, Pignat W, van den Bosch H, Pfeilschifter J: Suppression by cyclosporin A of interleukin 1 beta-induced expression of group II phospholipase A2 in rat renal mesangial cells. Br J Pharmacol 121: 787-793, 1997
7. Hoecherl K, Dreher F, Vitzthum H, Kohler J, Kurtz A: Cyclosporine A suppresses cyclooxygenase-2 expression in the rat kidney. J Am Soc Nephrol 13: 2427-2436, 2002
8. Granelli-Piperno A, Nolan P, Inaba K, Steinman RM: The effect of immunosuppressive agents on the induction of nuclear factors that bind to sites on the interleukin 2 promoter. J Exp Med 172: 1869-1872, 1990
9. Kunz D, Walker G, Eberhardt W, Nitsch D, Pfeilschifter J: Interleukin 1beta-induced expression of nitric oxide synthase in rat renal mesangial cells is suppressed by cyclosporin A. Biochem Biophys Res Commun 216: 438-446, 1995
10. Duymelinck C, Dauwe SE, Nouwen EJ, De Broe ME, Verpooten GA: Cholesterol feeding accentuates the cyclosporine-induced elevation of renal plasminogen activator inhibitor type 1. Kidney Int 51: 1818-1830, 1997
11. Duymelinck C, Deng JT, Dauwe SE, De Broe ME, Verpooten GA: Inhibition of the matrix metalloproteinase system in a rat model of chronic cyclosporine nephropathy. Kidney Int 54: 804-818, 1998
12. Davies M, Martin J, Thomas GJ, Lovett DH: Proteinases and glomerular matrix turnover. Kidney Int 41: 671-678, 1992
13. Ghiggeri GM, Altieri P, Oleggini R, Spada F, Ginevri F, Perfumo F, Gusmano R: Elective enhancement by cyclosporin A of collagen expression by mesangial cells 'in culture'. Eur J Pharmacol 270: 195-201, 1994
14. Eberhardt W, Huwiler A, Beck KF, Walpen S, Pfeilschifter J: Amplification of IL-1 beta-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappaB and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways. J Immunol 165: 5788-5797, 2000
15. Eberhardt W, Schulze M, Engels C, Klasmeier E, Pfeilschifter J: Glucocorticoid-mediated suppression of cytokine-induced matrix metalloproteinase-9 expression in rat mesangial cells: Involvement of nuclear factor-kappaB and Ets transcription factors. Mol Endocrinol 16: 1752-1766, 2002
16. Yokoo T, Kitamura M: Dual regulation of IL-1beta-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-kappaB and AP-1. Am J Physiol 270: F123-F230, 1996
17. Tibbles LA, Woodgett JR: The stress-activated protein kinase pathways. Cell Mol Life Sci 55: 1230-1254, 1999
18. Ichijo H: From receptors to stress-activated MAP kinases. Oncogene 18: 6087-6093, 1999
19. Sawada S, Suzuki G, Kawase Y, Takaku F: Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation. J Immunol 139: 1797-1803, 1987
20. Kung L, Halloran PF: Immunophilins may limit calcineurin inhibition by cyclosporine and tacrolimus at high drug concentrations. Transplantation 70: 327-335, 2000
21. Reynolds NJ, Al-Daraji WI: Calcineurin inhibitors and sirolimus: Mechanisms of action and applications in dermatology. Clin Exp Dermatol 27: 555-561, 2002
22. Sigal NH, Dumont FJ: Cyclosporin A, FK-506, and rapamycin: Pharmacologic probes of lymphocyte signal transduction. Annu Rev Immunol 10: 519-560, 1992
23. Bicknell GR, Williams ST, Shaw JA, Pringle JH, Furness PN, Nicholson ML: Differential effects of cyclosporin and tacrolimus on the expression of fibrosis-associated genes in isolated glomeruli from renal transplants. Br J Surg 87: 1569-1575, 2000
24. Pfeilschifter J, Vosbeck K: Transforming growth factor beta 2 inhibits interleukin 1beta-and tumour necrosis factor alpha-induction of nitric oxide synthase in rat renal mesangial cells. Biochem Biophys Res Commun 175: 372-379, 1991
25. Eberhardt W, Pluss C, Hummel R, Pfeilschifter J: Molecular mechanisms of inducible nitric oxide synthase gene expression by IL-1beta and cAMP in rat mesangial cells. J Immunol 160: 4961-4969, 1998
26. Sato H, Seiki M: Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8: 395-405, 1993
27. Baeuerle PA, Henkel T: Function and activation of NF-kappaB in the immune system. Annu Rev Immunol 12: 141-179, 1994
28. Matsuda S, Koyasu S: Mechanisms of action of cyclosporine. Immunopharmacology 47: 119-125, 2000
29. Alfonso-Jaume MA, Mahimkar R, Lovett DH: Co-operative interactions between NFAT (nuclear factor of activated T cells) c1 and the zinc finger transcription factors Sp1/Sp3 and Egr-1 regulate MT1-MMP (membrane type 1 matrix metalloproteinase) transcription by glomerular mesangial cells. Biochem J 380: 735-747, 2004
30. Sugimoto T, Haneda M, Sawano H, Isshiki K, Maeda S, Koya D, Inoki K, Yasuda H, Kashiwagi A, Kikkawa R: Endothelin-1 induces cyclooxygenase-2 expression via nuclear factor of activated T-cell transcription factor in glomerular mesangial cells. J Am Soc Nephrol 12: 1359-1368, 2001
31. Aramburu J, Yaffe MB, Lopez-Rodriguez C, Cantley LC, Hogan PG, Rao A: Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 285: 2129-2133, 1999
32. Guan Z, Buckman SY, Springer LD, Morrison AR: Both p38alpha (MAPK) and JNK/SAPK pathways are important for induction of nitric-oxide synthase by interleukin-1beta in rat glomerular mesangial cells. J Biol Chem 274: 36200-36206, 1999
33. Jurewicz WA: Tacrolimus versus cyclosporin immunosuppression: Long-term outcome in renal transplantation. Nephrol Dial Transplant 18: i7-i11, 2003
34. Islam M, Burke JF Jr, McGowan TA, Zhu Y, Dunn SR, McCue P, Kanalas J, Sharma K: Effect of anti-transforming growth factor-beta antibodies in cyclosporine-induced renal dysfunction. Kidney Int 59: 498-506, 2001
35. Gooch JL, Barnes JL, Garcia S, Abboud H: Calcineurin is activated in diabetes and is required for glomerular hypertrophy and ECM accumulation. Am J Physiol Renal Physiol 284: F144-F154, 2003
36. Pfeilschifter J: Mesangial cells orchestrate inflammation in the renal glomerulus. News Physiol Sci 9: 271-279, 1994
37. Meyer S, Kohler NG, Joly A: Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-kappaB activation. FEBS Lett 413: 354-358, 1997
38. Matsuda S, Koyasu S: Regulation of MAPK signaling pathways through immunophilin-ligand complex. Curr Top Med Chem 3: 1358-1367, 2003